PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $103,000 | -92.0% | 1,010 | -92.0% | 0.00% | -88.9% |
| Q1 2022 | $1,285,000 | -4.2% | 12,550 | 0.0% | 0.01% | +28.6% |
| Q4 2021 | $1,342,000 | -79.2% | 12,550 | -79.6% | 0.01% | -76.7% |
| Q3 2021 | $6,447,000 | -2.8% | 61,550 | 0.0% | 0.03% | -3.2% |
| Q2 2021 | $6,632,000 | +19.7% | 61,550 | +27.8% | 0.03% | +6.9% |
| Q1 2021 | $5,540,000 | -41.1% | 48,170 | -33.4% | 0.03% | -42.0% |
| Q4 2020 | $9,400,000 | +14.6% | 72,370 | 0.0% | 0.05% | -3.8% |
| Q3 2020 | $8,201,000 | +83.6% | 72,370 | +88.0% | 0.05% | +40.5% |
| Q2 2020 | $4,466,000 | +215.2% | 38,490 | +204.5% | 0.04% | +184.6% |
| Q1 2020 | $1,417,000 | – | 12,640 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $25,902,000 | 1.06% |
| PFM Health Sciences, LP | 19,807,000 | $20,605,000 | 0.61% |
| Partner Investment Management, L.P. | 193,000 | $201,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,430,000 | $4,581,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $21,253,000 | 0.27% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,176,000 | $25,210,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,381,000 | 0.07% |
| Verition Fund Management LLC | 1,415,000 | $1,472,000 | 0.04% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 4,298,000 | $4,470,000 | 0.03% |
| LOOMIS SAYLES & CO L P | 248,482 | $8,404,000 | 0.02% |